- Home
- RFIL vs LPCN Comparison
RFIL vs LPCN Comparison
Compare RFIL & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFIL
- LPCN
- Stock Information
- Founded
- RFIL 1979
- LPCN 1997
- Country
- RFIL United States
- LPCN United States
- Employees
- RFIL N/A
- LPCN N/A
- Industry
- RFIL Electrical Products
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- RFIL Technology
- LPCN Health Care
- Exchange
- RFIL Nasdaq
- LPCN Nasdaq
- Market Cap
- RFIL 43.0M
- LPCN 36.8M
- IPO Year
- RFIL N/A
- LPCN N/A
- Fundamental
- Price
- RFIL $4.07
- LPCN $5.46
- Analyst Decision
- RFIL Strong Buy
- LPCN Strong Buy
- Analyst Count
- RFIL 1
- LPCN 1
- Target Price
- RFIL $4.50
- LPCN $10.00
- AVG Volume (30 Days)
- RFIL 17.1K
- LPCN 23.4K
- Earning Date
- RFIL 09-16-2024
- LPCN 11-06-2024
- Dividend Yield
- RFIL N/A
- LPCN N/A
- EPS Growth
- RFIL N/A
- LPCN N/A
- EPS
- RFIL N/A
- LPCN N/A
- Revenue
- RFIL $62,278,000.00
- LPCN $4,800,930.00
- Revenue This Year
- RFIL N/A
- LPCN N/A
- Revenue Next Year
- RFIL $8.38
- LPCN N/A
- P/E Ratio
- RFIL N/A
- LPCN N/A
- Revenue Growth
- RFIL N/A
- LPCN 8630.55
- 52 Week Low
- RFIL $2.51
- LPCN $2.31
- 52 Week High
- RFIL $4.65
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- RFIL 53.18
- LPCN 61.75
- Support Level
- RFIL $4.02
- LPCN $4.89
- Resistance Level
- RFIL $4.14
- LPCN $5.85
- Average True Range (ATR)
- RFIL 0.13
- LPCN 0.38
- MACD
- RFIL -0.00
- LPCN 0.04
- Stochastic Oscillator
- RFIL 56.10
- LPCN 64.83
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. The company has operations in the United States, Canada, Israel, and Mexico.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.